Erythrocyte membrane-camouflaged mesoporous silica composite nanoparticles for loading and controlled release of the hepatoprotective agent silibinin: A-synthesis …
V Tayebi Khorrami, MJ Raee… - Journal of Pharmacy …, 2024 - academic.oup.com
Objectives Milk thistle has long been used in the treatment of liver and biliary disorders. In
the present study, to make a long-acting delivery system for silibinin (SBN, a major active …
the present study, to make a long-acting delivery system for silibinin (SBN, a major active …
Erythrocyte membrane-camouflaged mesoporous silica composite nanoparticles for loading and controlled release of the hepatoprotective agent silibinin: A-synthesis …
MJ Raee, SS Abolmaali, M Abedanzadeh… - The Journal of …, 2024 - europepmc.org
Objectives Milk thistle has long been used in the treatment of liver and biliary disorders. In
the present study, to make a long-acting delivery system for silibinin (SBN, a major active …
the present study, to make a long-acting delivery system for silibinin (SBN, a major active …
Erythrocyte membrane-camouflaged mesoporous silica composite nanoparticles for loading and controlled release of the hepatoprotective agent silibinin: A-synthesis …
VT Khorrami, MJ Raee, SS Abolmaali… - The Journal of … - pubmed.ncbi.nlm.nih.gov
Objectives Milk thistle has long been used in the treatment of liver and biliary disorders. In
the present study, to make a long-acting delivery system for silibinin (SBN, a major active …
the present study, to make a long-acting delivery system for silibinin (SBN, a major active …